Camber Capital Management
Latest statistics and disclosures from Camber Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UHS, PFE, THC, ZBH, VTRS, and represent 37.76% of Camber Capital Management's stock portfolio.
- Added to shares of these 10 stocks: PFE (+$249M), ZBH (+$90M), MDT (+$71M), SRPT (+$49M), GMED (+$36M), THC (+$30M), BMRN (+$27M), QDEL (+$24M), PTCT (+$20M), SKIN (+$20M).
- Started 5 new stock positions in BMRN, PFE, BCYC, QDEL, QGEN.
- Reduced shares in these 10 stocks: SNY (-$67M), QTRX (-$58M), WBA (-$51M), GSK (-$45M), EXEL (-$27M), , VTRS (-$25M), PRGO (-$21M), SEM (-$16M), MRTX (-$13M).
- Sold out of its positions in CNC, DVAX, GKOS.
- Camber Capital Management was a net buyer of stock by $309M.
- Camber Capital Management has $3.0B in assets under management (AUM), dropping by -1.21%.
- Central Index Key (CIK): 0001444043
Tip: Access up to 7 years of quarterly data
Positions held by Camber Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Camber Capital Management
Camber Capital Management holds 40 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Universal Hlth Svcs CL B (UHS) | 8.3 | $252M | +3% | 2.0M | 125.73 |
|
Pfizer Call Option (PFE) | 8.2 | $249M | NEW | 7.5M | 33.17 |
|
Tenet Healthcare Corp Com New (THC) | 7.9 | $241M | +14% | 3.7M | 65.89 |
|
Zimmer Holdings (ZBH) | 6.8 | $208M | +76% | 1.9M | 112.22 |
|
Viatris (VTRS) | 6.5 | $197M | -11% | 20M | 9.86 |
|
Sanofi Sponsored Adr (SNY) | 4.9 | $148M | -31% | 2.8M | 53.64 |
|
Medtronic SHS (MDT) | 3.9 | $118M | +150% | 1.5M | 78.36 |
|
Walgreen Boots Alliance (WBA) | 3.8 | $116M | -30% | 5.2M | 22.24 |
|
Baxter International (BAX) | 3.7 | $113M | 3.0M | 37.74 |
|
|
Myriad Genetics (MYGN) | 3.5 | $106M | 6.6M | 16.04 |
|
|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 3.4 | $104M | +19% | 10M | 10.20 |
|
GSK Sponsored Adr (GSK) | 3.4 | $103M | -30% | 2.9M | 36.25 |
|
Ionis Pharmaceuticals (IONS) | 3.4 | $102M | -10% | 2.3M | 45.36 |
|
Sarepta Therapeutics (SRPT) | 3.2 | $97M | +100% | 800k | 121.22 |
|
Select Medical Holdings Corporation (SEM) | 2.8 | $86M | -16% | 3.4M | 25.27 |
|
Globus Med Cl A (GMED) | 2.8 | $86M | +72% | 1.7M | 49.65 |
|
Ptc Therapeutics I (PTCT) | 2.5 | $76M | +36% | 3.4M | 22.41 |
|
Brookdale Senior Living (BKD) | 2.5 | $75M | 18M | 4.14 |
|
|
Mirati Therapeutics (MRTX) | 2.2 | $65M | -16% | 1.5M | 43.56 |
|
Dentsply Sirona (XRAY) | 2.0 | $60M | 1.8M | 34.16 |
|
|
Perrigo SHS (PRGO) | 1.9 | $59M | -26% | 1.9M | 31.95 |
|
Herbalife Com Shs (HLF) | 1.3 | $40M | +3% | 2.9M | 13.99 |
|
Quanterix Ord (QTRX) | 1.1 | $35M | -62% | 1.3M | 27.14 |
|
Replimune Group (REPL) | 1.1 | $34M | +29% | 2.0M | 17.11 |
|
Zimvie (ZIMV) | 1.0 | $31M | 3.3M | 9.41 |
|
|
The Beauty Health Company Com Cl A (SKIN) | 1.0 | $30M | +185% | 5.0M | 6.02 |
|
BioMarin Pharmaceutical (BMRN) | 0.9 | $27M | NEW | 300k | 88.48 |
|
OraSure Technologies (OSUR) | 0.8 | $25M | 4.3M | 5.93 |
|
|
Quidel Corp (QDEL) | 0.8 | $24M | NEW | 325k | 73.04 |
|
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.8 | $24M | 1.1M | 22.35 |
|
|
Peloton Interactive Cl A Com (PTON) | 0.7 | $23M | +50% | 4.5M | 5.05 |
|
Qiagen Nv Shs New (QGEN) | 0.5 | $16M | NEW | 400k | 40.50 |
|
Brookdale Sr Living Unit 11/15/2025 (BKDT) | 0.5 | $15M | 250k | 60.32 |
|
|
Curevac N V (CVAC) | 0.4 | $12M | +19% | 1.8M | 6.83 |
|
Puma Biotechnology (PBYI) | 0.4 | $11M | 4.2M | 2.63 |
|
|
Inogen (INGN) | 0.3 | $10M | +73% | 2.0M | 5.22 |
|
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.3 | $8.0M | NEW | 400k | 20.09 |
|
Exelixis (EXEL) | 0.2 | $6.6M | -80% | 300k | 21.85 |
|
Solid Biosciences Com New (SLDB) | 0.1 | $3.6M | 1.4M | 2.52 |
|
|
Cano Health Com Cl A | 0.0 | $1.0M | 4.0M | 0.25 |
|
Past Filings by Camber Capital Management
SEC 13F filings are viewable for Camber Capital Management going back to 2010
- Camber Capital Management 2023 Q3 filed Nov. 14, 2023
- Camber Capital Management 2023 Q2 filed Aug. 14, 2023
- Camber Capital Management 2023 Q1 filed May 15, 2023
- Camber Capital Management 2022 Q4 filed Feb. 14, 2023
- Camber Capital Management 2022 Q3 filed Nov. 14, 2022
- Camber Capital Management 2022 Q2 filed Aug. 15, 2022
- Camber Capital Management 2022 Q1 filed May 16, 2022
- Camber Capital Management 2021 Q4 filed Feb. 14, 2022
- Camber Capital Management 2021 Q3 filed Nov. 15, 2021
- Camber Capital Management 2021 Q2 filed Aug. 16, 2021
- Camber Capital Management 2021 Q1 filed May 17, 2021
- Camber Capital Management 2020 Q4 filed Feb. 16, 2021
- Camber Capital Management 2020 Q3 restated filed Nov. 16, 2020
- Camber Capital Management 2020 Q3 filed Nov. 16, 2020
- Camber Capital Management 2020 Q2 filed Aug. 14, 2020
- Camber Capital Management 2020 Q1 filed May 15, 2020